Revenue

After slashing debt to a decade low, Calfrac is leveraging its financial strength for strategic plays in Argentina's Vaca Muerta and next-gen North American tech.

Following its Qoria acquisition, Aura reports strong Q2 growth while cutting costs, signaling a bold strategy to build an end-to-end digital safety ecosystem.

Maxim Power Corp. posts a net loss as low electricity prices hit producers, but its modern M2 plant's strategic flexibility offers a silver lining.

BioStem Technologies' move from OTC to Nasdaq marks a pivotal moment, promising greater capital access and visibility for its innovative perinatal allografts.

Atlantic Petroleum faces a total write-down after a single pump failure at the Orlando Field, a stark reminder of the fragile web of dependencies in the North Sea.

Architectural products giant ADENTRA defies soft market conditions with strong Q2 results, revealing a strategy built on tech, M&A, and operational rigor.

Building materials giant Amrize reports strong Q2 growth fueled by data center and energy projects, yet faces a margin squeeze from stubborn inflation.

Alaris Equity Partners just posted record results, but the real story lies in its disciplined strategy. A low payout ratio and shrewd deals reveal a playbook for stable growth.

While others wait for the housing market to recover, James Hardie is building its own boom. A deep dive into the strategic execution driving its success.

RLJ Lodging Trust's stellar Q2 results weren't just a market beat; they were a validation of a shrewd strategy combining a lifestyle pivot with bold finance.

WM Technology's Q2 results show a puzzling split: higher net income but falling revenue and key metrics. Is this savvy cost-cutting or a sign of deeper trouble?

A steep revenue drop and slashed guidance at Xponential Fitness raise urgent questions about its franchise model and whether the boutique fitness craze has hit a wall.

With record revenues and a raised outlook, Ryman Hospitality's Q2 results reveal more than just strong bookings—they map the future of group travel.

The food-tech giant declared a routine dividend, but behind the curtain of record orders lies a significant asset writedown, raising questions about its health.

Bimini Capital's strong Q2 results reveal a radical shift, trading its mortgage portfolio for asset manager TJIM, creating a new, more stable model.

ESCO Technologies reports a stellar Q3 with 38% adjusted EPS growth and a record $1.5B backlog, proving its acquisition strategy is a powerful engine for growth.

X4 Pharmaceuticals secures a key European approval and overhauls its pivotal trial, signaling a major strategic shift backed by a newly extended cash runway.

A 5% revenue dip masks a surge in users and a high-stakes bet on a new 'Predictions' product. Is DraftKings sacrificing a quarter to win the war?

Starling Oncology just hit positive Adjusted EBITDA, a milestone for its value-based care model. Is this the inflection point for profitability in oncology?

Despite a dip in legacy revenue, Autoscope Technologies posts higher profits and doubles down on AI solutions aimed at making cities smarter and safer for all.